| BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis TE King Jr, J Behr, KK Brown, RM du Bois, L Lancaster, JA de Andrade, ... American journal of respiratory and critical care medicine 177 (1), 75-81, 2008 | 678 | 2008 |
| A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis I Noth, KJ Anstrom, SB Calvert, J De Andrade, KR Flaherty, C Glazer, ... American journal of respiratory and critical care medicine 186 (1), 88-95, 2012 | 546 | 2012 |
| Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis Idiopathic Pulmonary Fibrosis Clinical Research Network New England Journal of Medicine 370 (22), 2093-2101, 2014 | 542 | 2014 |
| Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial G Raghu, J Behr, KK Brown, JJ Egan, SM Kawut, KR Flaherty, FJ Martinez, ... Annals of internal medicine 158 (9), 641-649, 2013 | 538 | 2013 |
| Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis LH Lancaster, JA de Andrade, JD Zibrak, ML Padilla, C Albera, ... European respiratory review 26 (146), 2017 | 210 | 2017 |
| FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis G Raghu, MB Scholand, J De Andrade, L Lancaster, Y Mageto, J Goldin, ... European Respiratory Journal 47 (5), 1481-1491, 2016 | 181 | 2016 |
| Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis YT Ghebremariam, JP Cooke, W Gerhart, C Griego, JB Brower, ... Journal of translational medicine 13, 1-20, 2015 | 126 | 2015 |
| Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence L Richeldi, F Varone, M Bergna, J de Andrade, J Falk, R Hallowell, ... European Respiratory Review 27 (150), 2018 | 105 | 2018 |
| Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis C Moore, RZ Blumhagen, IV Yang, A Walts, J Powers, T Walker, M Bishop, ... American journal of respiratory and critical care medicine 200 (2), 199-208, 2019 | 104 | 2019 |
| Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosis FJ Li, R Surolia, H Li, Z Wang, T Kulkarni, G Liu, JA de Andrade, DJ Kass, ... The Journal of Immunology 199 (5), 1596-1605, 2017 | 86 | 2017 |
| Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction JD Christie, N Robinson, LB Ware, M Plotnick, J De Andrade, V Lama, ... American journal of respiratory and critical care medicine 175 (1), 69-74, 2007 | 84 | 2007 |
| ARTEMIS-IPF Investigators*. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial G Raghu, J Behr, KK Brown, JJ Egan, SM Kawut, KR Flaherty, FJ Martinez, ... Ann Intern Med 158 (9), 641-649, 2013 | 82 | 2013 |
| Plasma intercellular adhesion molecule‐1 and von Willebrand factor in primary graft dysfunction after lung transplantation M Covarrubias, LB Ware, SM Kawut, J De Andrade, A Milstone, ... American journal of transplantation 7 (11), 2573-2578, 2007 | 81 | 2007 |
| New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis Q Ding, T Luckhardt, L Hecker, Y Zhou, G Liu, VB Antony, J de Andrade, ... Drugs 71, 981-1001, 2011 | 74 | 2011 |
| Citrullinated vimentin mediates development and progression of lung fibrosis FJ Li, R Surolia, H Li, Z Wang, G Liu, T Kulkarni, AVF Massicano, ... Science translational medicine 13 (585), eaba2927, 2021 | 68 | 2021 |
| Alveolar epithelial disintegrity in pulmonary fibrosis T Kulkarni, J de Andrade, Y Zhou, T Luckhardt, VJ Thannickal American Journal of Physiology-Lung Cellular and Molecular Physiology 311 (2 …, 2016 | 68 | 2016 |
| Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts JA De Andrade, JP Crow, L Viera, C Bruce Alexander, K Randall Young, ... American journal of respiratory and critical care medicine 161 (6), 2035-2042, 2000 | 68 | 2000 |
| Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry L Snyder, ML Neely, AS Hellkamp, E O’Brien, J De Andrade, ... Respiratory research 20, 1-10, 2019 | 58 | 2019 |
| 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs R Surolia, FJ Li, Z Wang, H Li, G Liu, Y Zhou, T Luckhardt, S Bae, R Liu, ... JCI insight 2 (2), 2017 | 53 | 2017 |
| Patient registries in idiopathic pulmonary fibrosis DA Culver, J Behr, JA Belperio, TJ Corte, JA de Andrade, KR Flaherty, ... American journal of respiratory and critical care medicine 200 (2), 160-167, 2019 | 48 | 2019 |
